Posted on December 20, 2011 by Sitemaster
According to a report from Prof. Thomas Aherling on the UroToday web site, there were three interesting presentations related to nerve-sparing surgery at the recent World Conference of Endourology and SWL, in Kyoto Japan. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: nerve-sparing, outcome, radical prostatectomy, sexual function, surgery | Leave a comment »
Posted on July 18, 2011 by Sitemaster
A very small (pilot scale), randomized, clinical trial has provided some evidence that combining the use of a vacuum erection device (VED) with taldalafil (Cialis) drug therapy after bilateral, nerve-sparing robot-assisted laparoscopic prostatectomy (BNS-RALP) can improve the probability of return of erectile function post-surgery. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: bilateral, nerve-sparing, surgery, taldalafil, vacuum erection device, VED | Leave a comment »
Posted on September 9, 2010 by Sitemaster
The prostate cancer research team at Memorial Sloan-Kettering Cancer Center (MSKCC) has proposed and tested a new means for categorizing the amount of “damage” to the cavernous nerves as a method of predicting preservation of erectile function after radical prostatectomy. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: erectile function, nerve-sparing, NSS, outcome, score | 1 Comment »
Posted on May 1, 2009 by Sitemaster
And still the stream of information continues, with reports about frequency of PSA testing, nerve-sparing in men with Gleason 6 disease, and HIFU as a form of salvage therapy after first-line radiation: … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: frequency, HIFU, nerve-sparing, salvage, screening | 2 Comments »
Posted on January 16, 2009 by Sitemaster
In addition to the comments below about review articles on conservative therapy for low-risk, localized disease and eligibility of patients for focal therapy, there are some much more technical reports today on:
- Appropriate use of differing types of biopsy to predict potential for nerve-sparing surgery
- The hypothesis that oxidative stress may be related to risk for prostate cancer
- The role of neuroendocrine cell differentiation in development of prostate cancer … READ MORE …
Filed under: Diagnosis, Management, Prevention, Treatment, Uncategorized | Tagged: biopsy, neroendocrine cell differentiation, nerve-sparing, oxidative stress | Leave a comment »